Searched for
DIARRHOEA DRUG
Shigella scare in Kerala: Check symptoms, treatment and causes of the infection that killed 4-year-old in KozhikodeShigella Spreading in Kerala? Kerala has intensified surveillance and testing following its first reported Shigella-related death of a four...- India sends emergency medical supplies for Ebola outbreak response in CongoIndia has provided crucial pharmaceutical supplies to aid the fight against the Ebola outbreak in Congo. The Africa Centres for Disease Con...
- Zydus gets USFDA nod for generic IBS-D treatment drugZydus Lifesciences has secured tentative approval from the USFDA to market Rifaximin Tablets (550 mg) in the United States. This medication...
- USFDA approves Aurobindo's drugs for diarrhoea, allergyAurobindo now has a total of 224 ANDA approvals (196 final approvals, including 10 from Aurolife Pharma LLC and 28 tentative approvals) fro...
- Rural Indian children receive wrong treatments for deadly ailments: StudyBihar - where the study was conducted - has an infant mortality rate of 55 per 1000 live births, the highest in the country, researchers sa...
- Lupin gets USFDA approval for diarrhoea drugLupin Pharmaceuticals Inc (LPI), the company's US subsidiary would commence marketing the product shortly.
- Lupin inks licensing pact with US firm Romark Laboratories for diarrhoea drugLupin has inked a licensing pact with US-based pharma firm Romark Laboratories to market the latter's diarrhoea treatment drug 'Alinia'.
- What does Crofelemer approval mean for Glenmark?What does Crofelemer approval mean for Glenmark?
- Glenmark US partner Salix gets USFDA nod for Crofelemer tabletUS Food and Drug Administration provided marketing approval to its partner in US, Salix Pharmaceuticals, for Crofelemer 125 mg delayed-rele...
- Crofelemer approval a big positive for company: Glenn Saldanha, Glenmark Pharma"There is another $6 million that Salix is likely to pay us for the facility that we are working on for the supplies of Crofelemer."
- Glenmark gets DCGI nod for phase III trials of diarrhoea drugGlenmark Pharmaceuticals today said it has received approval from Drug Controller General of India (DCGI) to conduct phase III trials for C...
- Glenmark files arbitration claim against Napo PharmaceuticalsGlenmark has filed arbitration claims against Napo Pharmaceuticals for ending a contract to develop and market diarrhea drug.
- Glenmark achieves positive results for anti-diarrhoea moleculeGlenmark and Salix have also entered into a commercial supply agreement for Crofelemer active pharmaceutical ingredient.
- Glenmark Pharma: Miles to go before new drug makes a markGlenmark’s partners — US-based Napo Pharmaceuticals and Salix Pharmaceuticals — have announced completion of phase-III trials for the drug ...
- Glenmark moves closer to HIV drug launchGlenmark Pharmaceuticals has completed the third phase of human trials of Crofelemer, a new drug to treat HIV-related diarrhoea that could ...
- Over 44 fixed-dose combination drugs clear DGCI testsThe government may give permission to 44 more combination drugs - a formulation of two or more active ingredients combined in certain fixed...
- Bulk drug cos halve output on soaring ingredient costsFaced with a short supply and sharp increase in cost of raw materials imported from China, bulk drug manufactures in India have started sca...
- GlaxoSmithKline Pharma to launch more vaccines in IndiaDrug major GlaxoSmithKline Pharmaceuticals on MOnday said it would be launching more vaccines in the Indian market.
- Glenmark produces anti-diarrhoea ingredientGlenmark Pharmaceuticals Ltd on Friday said it has successfully produced active pharmaceutical ingredient (API), crofelemer, used for chron...
- Glenmark gets DGCI nod for drug trialGlenmark Pharmaceuticals Ltd today said it has received approval from the Drug Controller General of India (DCGI) to initiate phase II tria...
Load More
